Evidence map›Paper›PMID 25622574›Full record

ReviewBiochimie2015

Selenocysteine incorporation: A trump card in the game of mRNA decay.

Sumangala P Shetty, Paul R Copeland

Abstract readReview
In one paragraph

Review in Biochimie, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ribosome Fate during Decoding of UGA-Sec Codons.International journal of molecular sciences · 2021
    Review
  8. Human Genetic Disorders Resulting in Systemic Selenoprotein Deficiency.International journal of molecular sciences · 2021
    Review
  9. Article
  10. Article
  11. Article
  12. SECISBP2 is a novel prognostic predictor that regulates selenoproteins in diffuse large B-cell lymphoma.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Molecular mechanism of selenoprotein P synthesis.Biochimica et biophysica acta. General subjects · 2018
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Sumangala P ShettyDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, 675 Hoes Ln, Piscataway, NJ 08854, USA.
Paul R CopelandDepartment of Biochemistry and Molecular Biology, Rutgers-Robert Wood Johnson Medical School, 675 Hoes Ln, Piscataway, NJ 08854, USA. Electronic address: paul.copeland@rutgers.edu.
Johnson University · USRutgers, The State University of New Jersey · US

Funding

Functional Analysis of SBP2 and Selenocysteine IncorporationR01GM077073 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI COPELAND, PAUL R · 2006 to 2022
$5.5M
Expanding The Genetic Code In YeastR01GM094833 · NIGMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI COPELAND, PAUL R · 2010 to 2013
$1.2M
NIGMS NIH HHS GM077073NIGMS NIH HHS GM094833NIGMS NIH HHS R01 GM077073NIGMS NIH HHS R01 GM094833
6 · The paper itself

Abstract

The incorporation of the 21st amino acid, selenocysteine (Sec), occurs on mRNAs that harbor in-frame stop codons because the Sec-tRNA(Sec) recognizes a UGA codon. This sets up an intriguing interplay between translation elongation, translation termination and the complex machinery that marks mRNAs that contain premature termination codons for degradation, leading to nonsense mediated mRNA decay (NMD). In this review we discuss the intricate and complex relationship between this key quality control mechanism and the process of Sec incorporation in mammals.

Indexed as

Nonsense Mediated mRNA DecayAnimalsCodonHumansPeptide Elongation FactorsProtein BiosynthesisRNA-Binding ProteinsSelenocysteineCodonPeptide Elongation FactorsRNA-Binding ProteinsSECIS-binding protein 2, mouseSelenocysteinemRNA decayNMDSelenocysteine

Identifiers

PMID25622574
PMCPMC4458392
OpenAlexW1998484437

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.